ZA944725B - Recombinant antigens from mumps virus and their use in vaccines - Google Patents

Recombinant antigens from mumps virus and their use in vaccines

Info

Publication number
ZA944725B
ZA944725B ZA944725A ZA944725A ZA944725B ZA 944725 B ZA944725 B ZA 944725B ZA 944725 A ZA944725 A ZA 944725A ZA 944725 A ZA944725 A ZA 944725A ZA 944725 B ZA944725 B ZA 944725B
Authority
ZA
South Africa
Prior art keywords
vaccines
mumps virus
recombinant antigens
antigens
recombinant
Prior art date
Application number
ZA944725A
Inventor
Alex Bollen
Sophie Houard
Erling Carl Jocob Norrby
Tamas Mark Varsanyi
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Priority to ZA944725A priority Critical patent/ZA944725B/en
Publication of ZA944725B publication Critical patent/ZA944725B/en

Links

ZA944725A 1994-06-30 1994-06-30 Recombinant antigens from mumps virus and their use in vaccines ZA944725B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA944725A ZA944725B (en) 1994-06-30 1994-06-30 Recombinant antigens from mumps virus and their use in vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA944725A ZA944725B (en) 1994-06-30 1994-06-30 Recombinant antigens from mumps virus and their use in vaccines

Publications (1)

Publication Number Publication Date
ZA944725B true ZA944725B (en) 1996-01-30

Family

ID=25584056

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944725A ZA944725B (en) 1994-06-30 1994-06-30 Recombinant antigens from mumps virus and their use in vaccines

Country Status (1)

Country Link
ZA (1) ZA944725B (en)

Similar Documents

Publication Publication Date Title
CY2614B2 (en) Combined vaccines comprising Hepatitis B surface and other antigens
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
EP0958364A4 (en) Immunotherapy and improved vaccines
AU4556597A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
ZA952563B (en) Recombinant viruses their preparation and their use in gene therapy
HUP0000356A3 (en) Vectors based on recombinant defective viral genomes,and their use in the formulation of vaccines
GB2264949B (en) Measles virus recombinant poxvirus vaccine
HUP9901958A3 (en) Porcine reproductive and respiratory syndrome vaccine
IL131212A0 (en) Recombinant virus and live-virus vaccines
EP0747482A3 (en) Hepatitis GB virus recombinant proteins and uses thereof
GB9516293D0 (en) Novel peptides and their use as vaccines
ZA952242B (en) Recombinant viruses their preparation and their use in gene therapy
ZA944725B (en) Recombinant antigens from mumps virus and their use in vaccines
EP0745133A4 (en) Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
EP0723584A4 (en) Recombinant infectious laryngotracheitis virus and uses thereof
AU2946395A (en) Recombinant infectious laryngotracheitis virus and vaccine
EP0690917A4 (en) Recombinant epstein-barr virus protein and its use in vaccine
ZA952244B (en) Recombinant viruses their preparation and their use in gene therapy
IL96647A0 (en) Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
HU9702540D0 (en) Carrying matherial for virus vaccine administered in intranasal way and virus vaccine itself
GB9611334D0 (en) Viral antigens and their preparation
ZA936199B (en) Recombinant antigens and vaccines of bovine ephemeral fever virus
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy